Rezulin (REZ-u-lin, troglitazone), for Type II diabetes
The FDA is getting close to approving Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.
It'll be the first drug in a new class of meds for diabetes.
Troglitazone helps reduce insulin resistance...an underlying metabolic defect in most patients with Type II diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote